Selected Publications

Bod L, Kye YC, Shi J, Torlai Triglia E, Schnell A, Fessler J, Kuchroo JR, Barilla RM, Zaghouani S, Christian E, Delorey TM, Mohib K, Xiao S,Rothstein DM, Rozenblatt-Rosen O, Sharpe AH, Apetoh L, Regev A, Kuchroo V.K: B-cell specific checkpoint molecules that regulate anti-tumor immunity. Nature 619, pages348–356 (2023). 

Schnell A, Bod L, Madi A, Kuchroo VK. (2020). The yin and yang of co-inhibitory receptors: toward antitumor immunity without autoimmunity. Cell Res, 30(4), 285-299.

Xiao S, Bod L, Pochet N, Kota SB, Hu, D, Madi A, Kilpatrick J, Shi J, Ho A, Zhang H, Sobel R, Weiner HL, Strom TB, Quintana FJ, Joller N, Kuchroo VK. (2020). Checkpoint Receptor TIGIT Expressed on Tim-1(+) B Cells Regulates Tissue Inflammation. Cell Rep, 32(2), 107892.

Bod L, Douguet L, Auffray C, Lengagne R, Bekkat F, Rondeau E, Molinier-Frenkel V, Castellano F, Richard Y, Prevost-Blondel A. (2018). IL-4-Induced Gene 1: A Negative Immune Checkpoint Controlling B Cell Differentiation and Activation. J Immunol, 200(3), 1027-1038.

Bod L, Lengagne R, Wrobel L, Ramspott JP, Kato M, Avril MF, Castellano F, Molinier-Frenkel V, Prevost-Blondel A. (2017). IL4- induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma. Oncoimmunology, 6(3), e1278331.


Full bibliography could be found here.